Ads
related to: multiple myeloma treatment- Contact a Representative
For Questions and Information
About This Treatment
- Phase 3 Trial
Explore the Phase 3 Trial Design,
Results, and Patient Population
- Primary and Subgroup Data
Primary- and Subgroup-
Specific Data
- Patient Profile
Potential Treatment Candidates
HCPs, See Who May Be Appropriate
- Contact a Representative
Search results
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated ...
Benzinga via Yahoo Finance· 9 hours agoThe data were presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. On...
GSK blood cancer drug nearly halves risk of death in late-stage trial | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 2 days agoGSK’s multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared...
Advances in CAR T-Cell Therapy for Multiple Myeloma
MedPage Today· 4 days agoB-cell maturation antigen (BCMA)-directed CAR T-cell therapies are now established options for treating multiple myeloma after relapse, but efforts are...
Take targeted action against cancer pain
Weston Forum· 18 minutes agoOncologic pain is a heterogeneous phenomenon with somatic, visceral, and neural components. Effective treatment of cancer pain must take this variability into account and ...
Quadruplet Regimens Have Become Standard for Multiple Myeloma
MedPage Today· 4 days agoWhile triplet regimens were once standard for newly diagnosed multiple myeloma, more recent studies...
GSK builds case for return of multiple myeloma drug Blenrep
BioPharma Dive via Yahoo Finance· 2 days agoStudy results showed the antibody-drug conjugate helped stave off disease progression better than a...
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma - Blood...
Nature· 4 days agoB-cell-maturation-antigen (BCMA)-directed therapies are highly active for multiple myeloma, but infections are emerging as a major challenge. In this retrospective ...
Top 10 most common cancers among Blacks
Rolling Out· 5 days agoUnderstanding the most common cancers among African Americans is crucial for improving prevention, early detection, and treatment strategies.
FDA accepts Sanofi’s Sarclisa sBLA for priority review
Pharmaceutical Technology via Yahoo Finance· 7 days agoSanofi Development global head and chief medical officer Dietmar Berger stated: “Despite recent...
Factor Bioscience Successfully Defends Three U.S. Patents Covering Foundational Methods for...
KOLR - KSFX Ozarks· 7 days ago-Patented methods relate to multiple allogeneic CAR T-cell therapies under clinical development for the treatment of B-cell lymphoma, chronic lymphocytic ...
Ads
related to: multiple myeloma treatment